Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
about
Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikisSialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide.miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation.β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbationsUpregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer.Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma.Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.α-2,8-Sialyltransferase Is Involved in the Development of Multidrug Resistance via PI3K/Akt Pathway in Human Chronic Myeloid Leukemia.Risk score based on three mRNA expression predicts the survival of bladder cancer.Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells.Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia.
P2860
Q26742115-C642990B-36E4-42B2-8FA5-5D1E5C362A30Q28539547-D52417DD-DEA0-4C36-8670-BE685C5E3B6CQ33650423-54750A23-40B5-4C68-B3C5-D060A0D264A8Q33709554-E0680DBE-DEC9-4892-9FDC-1A101020FF94Q33947085-64081D1B-2AA3-46B3-8195-6CF4149B7D59Q34683204-0F1A5788-A6C8-446A-A226-3680BC1A4DFFQ35841848-7ECCF612-8EDD-4AB9-AD05-1964658DECD5Q36962620-7FF43547-ECE2-4738-B7D6-9D23818535AFQ37644988-A0F2FC91-8FA9-4D50-A093-3799C0496536Q38287959-2EA08F8F-0540-486F-86CF-1D64C1B09ADEQ38446053-D5F98905-391E-44EB-ADFE-B169A0259CEFQ38815505-31983748-DBE9-472C-8245-4D26A22953D6Q38818166-6BC13A6F-627D-45F1-87B4-5830774C04C2Q38889539-DDE92EB0-173F-4993-99FC-57DFDF8AF9A2Q42125441-B3FBED66-39B4-433F-ADE9-8A896C7CB346Q48000463-A59F1C31-069A-41C8-B675-EA90FFE09BC5Q50055562-ECB8C16B-F9F3-4575-B881-3D3E244F397EQ55027119-A95A8AF2-C50A-4939-80C1-B25F083B9723
P2860
Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Modification of sialylation is ...... human acute myeloid leukemia.
@en
Modification of sialylation is ...... human acute myeloid leukemia.
@nl
type
label
Modification of sialylation is ...... human acute myeloid leukemia.
@en
Modification of sialylation is ...... human acute myeloid leukemia.
@nl
prefLabel
Modification of sialylation is ...... human acute myeloid leukemia.
@en
Modification of sialylation is ...... human acute myeloid leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Modification of sialylation is ...... human acute myeloid leukemia.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2014.7
P407
P577
2014-02-17T00:00:00Z